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Abstract
Objectives: To determine the incidence of computed tomography (CT) identifiable Randall plaques in a
CT explored population; to determine the clinical relevance of this radiological finding by a 7-year
follow-up; to determine a cut point to identify a population with high risk of developing calcium stone
disease (SD).
Materials and Methods: Retrospective study of all patients explored by abdominal CT in our center between
January and March 2005. Inclusion criteria: age 30–60 years and no SD. Papillae attenuation was measured on
nonenhanced CT in Hounsfield units (HU) and the mean of all papillae was calculated. Patients were re-
evaluated after 7 years to identify calcium stone formers. Anamnesis and already available CT, ultrasound,
kidney, ureter, and bladder radiograph (KUB) or intravenous urography (IVU) images performed as part of their
follow-up were used. In patients with no follow-up, ultrasound and KUB were to be performed. Pearson
correlation, Student t-test, and the receiver operator curve were used for statistical analysis.
Results: A total of 362 patients fulfilled the inclusion criteria and were analyzed; 12 developed calcium SD after
7 years. A significant difference was encountered between the papillae attenuation of stone formers (SF) versus
non-SF (47.2HU vs. 35.5HU, p = 0.001). There was good correlation between papillae attenuation and the
possibility of developing SD (R = 0.87). An optimal cut point of 43HU with a sensitivity of 81% and specificity
of 97%, area under the curve 0.91, separated SF and non-SF.
Conclusion: Patients with high papillae density have a higher risk of developing SD. A cut point of 43HU could
accurately be used to identify a high-risk population.
Introduction
Renal papillae tip microcalcifications are thought tobe the nuclei for the development of stones.1 They have
been described in calcium oxalate stone formers2 and similar
calcium accumulations in the distal area of the renal papillae
were also described in brushite stone formers and in patients
with enteric hyperoxaluria,3 accounting for the large majority
of calcium stone (CS) formers.
Previous studies have proven that papillae’s tip incre-
ment of density can be identified by an unenhanced CT-
scan (uCT) in patients with active stone disease (SD)4–6
being present only in the region corresponding to the tip
of the renal papillae.7 These findings support Randall’s
theory of stone formation. The same modification in the
distal renal papillae was identified even when active SD
was not present, before its development.7 However, im-
portant questions over the real incidence and prevalence of
these findings and its clinical applicability still remain
unanswered.
The objective of our study was to determine the clinical
relevance of the Randall plaques identified in abdominal CT
images. For that purpose, we decided to evaluate the inci-
dence of uCT identifiable Randall plaques in a uCT explored
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population; to monitor the evolution of these patients after a
7-year follow-up, and to determine a radiological measure-
ment cut point that would allow us to identify a population
with high risk for developing SD.
Patients and Methods
We retrospectively reviewed 1000 consecutive patients
explored by abdominal CT in our center between January and
March 2005 to have a minimum follow-up of 7 years. We
performed a cohort study to identify the outcome of our uCT
explored population. The inclusion criteria were as follows:
(1) no history of SD;
(2) no SD on the uCT performed in our center;
(3) no conditions predisposing to stone development (hyper-
parathyroidism, intestinal inflammatory disease, etc.);
(4) no chronic renal failure, patients with acute renal
failure were included if normalization of serum cre-
atinine could be documented;
(5) No malignant diseases.
The reason for performing the abdominal uCT did not
influence the eligibility for the study, except in patients who
underwent uCT for SD. Patients who underwent nephrec-
tomy or died during follow-up were excluded.
All CTs were performed for clinical or diagnostic purposes
other than renal lithiasis as part of the standard protocols of
our center. The study adheres to local regulations and stan-
dards and was approved by the Institutional Review Board.
A uCT was performed on Siemens (Erlangen, Germany)
CTmultidetector scanners (Emotion Duo or Sensation 64). In
all cases, coronal reformatted images were obtained. In those
patients who had nephrographic and excretory phases, these
were used together with the unenhanced one for a better lo-
calization of the renal papillae. The examinations were done
with 5mm slice thickness reconstruction. In some patients,
1mm slice thickness reconstructions were also obtained. As
1mm slices were not available in all patients, we performed the
measurements using the 5mm slides. A subanalysis of the
patients where 1mm slices were available was performed,
comparing the results with the 5mm slices of the same patients.
The CT images were reviewed using the Raim Alma 2010
(ªALMA IT SYSTEMS, Barcelona, Spain) software. Pa-
tients were reviewed consecutively. The reviewers had no
knowledge of subsequent imaging in those patients who
might have developed SD in the follow-up. Each kidney was
divided into three parts corresponding to the three caliceal
groups; in each one the density of the renal papillae was
recorded.
Renal papilla attenuation was measured in Hounsfield
units (HU) by placing regions of interest (ROIs) with a mean
size of 0.1 cm2 over the tip of the papilla (Fig. 1). The images
were magnified to 5· to prevent contamination of the ROIs
with fat of the renal sinus. Each kidney was divided into three
parts corresponding to the three caliceal groups; in each one
the attenuation of the renal papillae was recorded. A total of
six measurements for each patient were recorded, three in
each kidney using unenhanced CT images. In every kidney,
one papilla from each caliceal group was measured, choosing
the easiest to identify. The mean attenuation was calculated
for each kidney.
The patients who fulfilled the inclusion criteria were re-
evaluated in 2013 after a mean interval of 7 years. Medical
history was updated in all patients. If available, abdominal
CTs, abdominal ultrasound, and kidney, ureter, and bladder
radiograph (KUB) or intravenous urography (IVU), already
performed as part of their follow-up by different specialties,
were used. In patients with no active follow-up between 2005
and 2013, ultrasound and KUB were performed. Ultrasound
alone as evidence of SD was not accepted because of the
possibility of uric acid stones. KUB was considered neces-
sary in these patients to support the diagnosis of CS.
For the evaluation of the composition of stones, in the case
of stones already obtained and analyzed, the result was reg-
istered. For the rest of the stones, we used surrogate markers
as the unenhanced CT attenuation (a cut point of 600HU was
used to separate uric acid and CS), and if CT images were not
available, clear visibility on plain x-ray films was considered
suggestive of CS. In all stone patients, urine bacterial cultures
were registered.
For the statistical analysis, we defined two groups: calcium
stone-forming patients (CSF) and nonstone-forming patients
FIG. 1. Renal papillae Houns-
field attenuation values measured
by placing regions of interest over
the tip of the papilla.
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(NSF). Pearson correlation coefficient was used to evaluate
the correlation between the renal papillae attenuation and the
possibility of developing SD. The two-tailed independent
sample t-test and the Wilcoxon signed-rank test were used to
test the significance of differences between groups. A p value
inferior to 0.05 was considered significant from a statistical
point of view. A receiver operator curve (ROC) analysis was
used to define a cut point between CSF and NSF that could
help characterize a high-risk population. The relative risk to
develop calcium SD was calculated for this population. The
Bland Altman analysis was used to evaluate the mean dis-
persion of attenuation values between the papillae of the
same kidney.
Results
Demographics
The first consecutive 1000 patients who underwent ab-
dominal CT between January and March 2005 were evalu-
ated. SD prevalence was 8.6%. Another 1.2% had a prior
history of SD although they had no evidence of SD on the
2005 CT. A total of 576 patients fulfilled the inclusion cri-
teria, 177 patients were lost to follow-up, and 37 patients
died. A total of 362 patients were analyzed. Patients’ de-
mographic data can be found in Table 1. In the follow-up, 87
patients had a recent (less than a year) CT and 163 a recent
ultrasound.
Follow-up stone status outcome
Of the total of 362 patients, 12 patients (3.3%) devel-
oped SD after 7 years. SD was diagnosed in 10 of the CTs
and 2 of the ultrasounds. One hundred twelve patients had
no follow-up and underwent ultrasound showing presence
of SD in 1 case. Both patients diagnosed by ultrasound had
clearly radioopaque stones on KUB and these were con-
sidered CS.
In one patient, the stone attenuation measured on abdom-
inal CT images was lower than 600HU (237HU) and con-
sidered as uric acid stones. In all other patients, the stone
attenuation measured on uCT was superior to 600HU, the
lowest one being 619HU, and considered as CS. Stone
analysis was available in seven patients who also had avail-
able CT images, confirming calcium oxalate composition.
All stone patients had negative urine culture.
Of the 12 patients, 7 were symptomatic and required
treatment (4 medical expulsive treatments with spontaneous
expulsions, 2 external shock wave lithotripsy, and 1 uretero-
renoscopy). The mean stone size was 4mm (3–6mm)
for symptomatic and 2mm (1–3mm) for nonsymptomatic
patients.
Table 1. Patient Demographics
NSF Calcium SF p
Patient number 351 11 —
Mean age 47.3 years 48.1 years 0.76
Percentage of women 53% 57% 0.64
Mean serum creatinine 1.13 1.10 0.54
Mean papillae
attenuation in HU
35.5HU 47.2HU 0.001
FIG. 2. Distribution of renal papillae attenuation. Black represents stone-forming patients, gray—nonstone-forming
patients.
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The baseline distribution of the attenuations of the tip of
the papillae measured on abdominal CT images was conti-
nuous and is shown in Figure 2.
Statistical groups
A total of 11 patients (3.03%) developed CS after a mean
follow-up of 7 years and were included in the CSF statistical
group. The uric acid stone formers were not included in the
statistical analysis. The remaining 351 patients were con-
sidered as the NSF group.
Statistical analysis results
There was a significant difference between the mean pa-
pillae attenuation of patients who developed calcium SD
when compared with the NSF group (47.2HU versus
35.5HU, p= 0.003). There were no significant differences
between the SF and NSF group from a demographical point
of view (Table 1).
We found a good correlation between the attenuation of the
renal papillae and the possibility of developing SD (R = 0.87).
Age showed a poor correlation with the presence of a higher
attenuation or a higher risk of developing SD (R= 0.37). On
multivariate analysis, renal papillae attenuation was the only
predictor for the development of SD.
A cut point of 43HU showed the optimal combination of
sensitivity (81%) and specificity (97.7%) in the ROC with an
area under the curve of 0.91 (Fig. 3). A total of 53% of the
patients with papillae density higher than 43HU developed
calcium SD after 7 years. Up to 81% of the CSF patients had a
papillae density higher than 43HU, whereas only 19% had
attenuation lower than 43HU.
High papillae attenuation values (> 43HU) were associ-
ated with a higher risk of developing an SD episode (an odds
ratio of 91.05).
A total of 155 patients had 1mm slices available for
analysis. The papillae attenuation measurements per-
formed on these slices were compared with those per-
formed in the same patients using the 5mm slices. We
identified no significant slice thickness dependent differ-
ences (36.2HU in 5mm slices versus 36.4HU in 1mm sli-
ces, p = 0.52).
The mean dispersion of papillae tip attenuation was 1,2HU
for the papillae of the same kidney. The difference between
the left and right kidney was not significant from a statistical
point of view (47.1 versus 47.3HU, p = 0.92).
Discussion
The Randall plaque theory postulates that small calcifica-
tions appear beneath the urothelium, grow and break through
it, and finally evolve to develop CS.1,8 The presence of these
small calcifications changes the CT attenuation of the pa-
pillae tip. Various studies showed that uCT can be used to
identify the presence of these small calcium deposits.4–7 The
incidence and the normal evolution of these small calcifica-
tions were unknown.
The incidence of CS was always closely related to the
presence of the Randall plaques. The 7-year cumulated in-
cidence of lithiasis in our population was 3.9% and 3.5% for
CS, whereas the prevalence in the Spanish general population
is 5% to 14%9 and in the European population 5% to 10%.10
The slightly higher incidence in our study is probably due to
the fact that we chose the population group with the highest
incidence for SD (30–60 years).
Our study comes to strengthen the relationship between the
calcifications of the tip of the renal papillae and the devel-
opment of CS, as the incidence of CS in our population was
closely related to the presence of higher quantities of calcium
in the tip of the renal papillae. The cut point of 43HU can be
used in two ways. Patients with papillae tip attenuation
> 43HU can be identified as a high-risk group with a possi-
bility of 53% developing SD over 7 years. On the other hand,
patients with papillae tip attenuation <32HU had an SD in-
cidence of 0%. In addition, we encountered a continuous
distribution of attenuation values with good correlation be-
tween the papillae tip attenuation and the possibility of de-
veloping SD, higher attenuations being related to a higher
risk. All this leads to the idea that the attenuation interval
comprised between 32 and 43HU acts as a growth stage or
level of development key point, marking the moment of
sufficient accumulation of calcium when the calcification
breaks through the urothelium and evolves to a real active
stone nucleus that begins to catalyze the deposit of crystals
initiating stone growth.
The lack of differences between papillae attenuation of the
two kidneys and the stretch dispersion of papillae tip atten-
uation values in the same kidney suggests a diffuse change in
papillae tip attenuation, involving all papillae. Previous
studies have determined that papillae tip attenuation was
similar between stone forming and stone free kidney of pa-
tients with unilateral stones. The results of our study further
support the idea that this modification might be present in all
the papillae of the same patient.
The population analyzed in our study is not a sample of a
general population, but represents the population undergo-
ing abdominal uCTs in a general hospital. As the abdominal
CT is more and more accessible and used for diagnosis, this
population is growing. This is the target population for
clinical applicability of this concept, as in this population,FIG. 3. The receiver operator curve (ROC) distribution.
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the early diagnosis of calcifications in the tip of the renal
papillae and the identification of a high-risk group could be
possible.
The initial diagnosis, which established that all patients
were stone free, was performed with an abdominal CT.
One of the limitations of our study is the fact that for the
follow-up, we used not only abdominal CT images but also
ultrasound and KUB/IVU images. The abdominal CT has a
high sensitivity and specificity of 98% and 100%, re-
spectively.11 Abdominal ultrasound has a sensitivity, de-
scribed in prospective studies, of 44%–81% and specificity
of 82%–100%.11,12 KUB also has a sensitivity of 44%–
77% and specificity of 80%–87% with IVU having better
detection rates especially for ureteral stones up to 96%.11
The use of ultrasound and KUB alongside the abdominal
CT for the follow-up might have, due to a lower sensi-
tivity, failed to diagnose some asymptomatic patients with
active SD. On the other hand, ultrasound and, to a lesser
extent, KUB are widely used today for follow-up and
screening for SD and for that, our results are similar to real
daily practice results.
One of the limitations of our study could be the fact that we
included patients who were scanned using two different CT
scanners. This can be criticized from the point of view of
measured attenuation because there might be differences in
the contrast and noise of the imaging data. Nonetheless, an
inclusion criterion was the requirement that all uCTs were
performed in our center. Our scanners are fine-tuned by
the manufacturer (the same for both machines) to produce
similar/identical results and thus, attenuation measured on a
CT scan acquired by any of our scanners should generate the
same result.
In addition, the use of 5mm slice thickness could be crit-
icized. When reconstructing the CT slices, the computer uses
volume averaging to calculate the mean density of the tissues
in a slice. When bigger slice thickness is used, more tissue is
condensed into the same image on CT, changing the final
measured attenuation. Therefore, small calcifications could
get diluted. The attenuation results could be lower when
measured in 5mm slice thickness than when using 1mm
slides. However, subanalyses of the patients who had 1mm
slides available demonstrated that there were no significant
slide thickness dependent differences.
Another limitation is the fact that not all the stones were
obtained and analyzed. We used surrogate criteria like vis-
ibility on plain KUB or uCT attenuation value. Stone ra-
dioopacity is widely accepted as a good criterion for the
diagnosis of CS.13 The abdominal CT also has a high
sensitivity and specificity of 92% and 61% for the differ-
ential diagnosis of uric acid and CS.14 The lowest attenu-
ation for a CS measured on uCT was 619HU, and all
patients had negative urine cultures. Previous studies
showed that a cut point of 600HU has a high sensitivity and
specificity for separating uric acid and CS.14 All stones
identified by KUB/IVU were radioopaque, and the patients
had negative urine cultures, all this being highly suggestive
of CS.
The design of our study did not allow for a direct analysis
of stones in most cases. That generates the possibility of
having included patients with struvite stones, as the HU
density of struvite stones is similar to that of CS. Clearly, a
negative urine culture cannot exclude the possibility of a
struvite stone. Nonetheless, patients with struvite stones are
known to have to a greater degree positive urine cultures.
Results from different studies are variable ranging up to 88%
versus 26% for calcium stone formers.15,16 The fact that all
urine cultures came out negative does not exclude struvite
stone, but at least lowers the possibility of having included
patients with struvite stones.
The Randall theory explained the formation of stones, but
had no translation to clinical practice. Nonetheless, the pos-
sibility of measuring in a quantitative manner, the presence of
calcium deposits in the tip of the renal papillae opened a
possibility for this theory to be brought to day-to-day clinical
practice. A cut point of 43HU identifies a population that
has a 53% chance of developing SD over 7 years. Further-
more, higher attenuation values are indicators of higher risk
of developing SD. This gives us the possibility of identifying
people at risk among those who undergo abdominal CT for
whatever reason and to offer them personalized counsel and,
if needed, prophylactic therapy.
Conclusion
Patients with high papillae density have a higher risk of
developing SD. These findings reinforce the Randall’s plaque
theory of stone formation. A cut point of 43HU could accu-
rately be used to identify a high-risk population.
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Abbreviations Used
CS¼ calcium stones
CSF¼ calcium stones formers
CT¼ computed tomography
HU¼Hounsfield units
IVU¼ intravenous urography
KUB¼ kidney, ureter, and bladder radiograph
NSF¼ nonstone formers
ROC¼ receiver operator curve
ROIs¼ regions of interest
SD¼ stone disease
SF¼ stone formers
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